Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

This study has been completed.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals ) Identifier:
First received: April 11, 2005
Last updated: November 22, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2007
  Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)